Results
1
-
10
of
42
<
1
2
3
4
5
>
Hu et al..
Zinc activates damage-sensing TRPA1 ion channels
,
Nature Chemical Biology, 2009
[DOI: 10.1038/nchembio.146]
Qi R; Ping QN; Zhao W.
[Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
,
Yao xue xue bao = Acta pharmaceutica Sinica
[PubMed: 15040094]
Bittner B; McIntyre C; Tian H; Portron A; Jordan P; Schmidt J; Tang K; Shah N; Phuapradit W; Ahmed H; Chokshi H; Infeld M; Fotaki N; Ma H.
Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC).
,
Die Pharmazie
Malkov D; Angelo R; Wang HZ; Flanders E; Tang H; Gomez-Orellana I.
Oral delivery of insulin with the eligen technology: mechanistic studies.
,
Current drug delivery
Qi R; Ping QN; Xu RY; Shi YP.
[Effect of casein and protamine on the enzymatic degradation and the orally hypoglycemic action of insulin].
,
Yao xue xue bao = Acta pharmaceutica Sinica
Berkowitz SD; Marder VJ; Kosutic G; Baughman RA.
Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty.
,
Journal of thrombosis and haemostasis : JTH
Malkov D; Wang HZ; Dinh S; Gomez-Orellana I.
Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate.
,
Pharmaceutical research
Pineo GF; Hull RD; Marder VJ.
Orally active heparin and low-molecular-weight heparin.
,
Current opinion in pulmonary medicine
Gonze MD; Salartash K; Sternbergh WC 3rd; Baughman RA; Leone-Bay A; Money SR.
Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.
,
Circulation
Gonze MD; Manord JD; Leone-Bay A; Baughman RA; Garrard CL; Sternbergh WC 3rd; Money SR.
Orally administered heparin for preventing deep venous thrombosis.
,
American journal of surgery
<
1
2
3
4
5
>